Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

1,406

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

1,406 results for “Migraine”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov36/100

Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only)

ClinicalTrials.gov study NCT05399459. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Calcitonin Gene-related Peptide Levels in Chronic Migraine

ClinicalTrials.gov study NCT01071096. IPD Sharing: Not stated. Countries: 1. Publications: 7.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Migraine Study in Adolescent Patients

ClinicalTrials.gov study NCT00843024. IPD Sharing: YES. Countries: 1. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine

ClinicalTrials.gov study NCT04408794. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention

ClinicalTrials.gov study NCT01952574. IPD Sharing: YES. Countries: 7. Publications: 9.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Real-world Data Analysis of REN Treatment in Adolescence With Migraine

ClinicalTrials.gov study NCT05443659. IPD Sharing: NO. Countries: 2. Publications: 7.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine

ClinicalTrials.gov study NCT02621931. IPD Sharing: Not stated. Countries: 9. Publications: 8.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine

ClinicalTrials.gov study NCT05216263. IPD Sharing: YES. Countries: 1. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Prevention Study in Adult Patients Suffering From Migraine Headaches

ClinicalTrials.gov study NCT00742209. IPD Sharing: Not stated. Countries: 2. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Effectiveness of Onabotulinumtoxin A (Botox) in Pediatric Patients Experiencing Migraines: A Study in the Pediatric Pain Population

ClinicalTrials.gov study NCT03055767. IPD Sharing: NO. Countries: 1. Publications: 14.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)

ClinicalTrials.gov study NCT00382993. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

ClinicalTrials.gov study NCT05518123. IPD Sharing: YES. Countries: 14. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Study to Evaluate the Efficacy of Intranasal Kinetic Oscillation Stimulation in the Preventive Treatment of Chronic Migraine

ClinicalTrials.gov study NCT03400059. IPD Sharing: NO. Countries: 2. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache

ClinicalTrials.gov study NCT02163993. IPD Sharing: Not stated. Countries: 1. Publications: 4.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Comparative Study Between Valproate and Memantine in the Prophylactic Management of Episodic Migraine.

ClinicalTrials.gov study NCT04698525. IPD Sharing: YES. Countries: 1. Publications: 6.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura

ClinicalTrials.gov study NCT02614287. IPD Sharing: YES. Countries: 6. Publications: 4.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine

ClinicalTrials.gov study NCT02629861. IPD Sharing: Not stated. Countries: 9. Publications: 6.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Statin/Vitamin D & Migraine Study

ClinicalTrials.gov study NCT01225263. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention

ClinicalTrials.gov study NCT03238781. IPD Sharing: YES. Countries: 8. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

ClinicalTrials.gov study NCT05509400. IPD Sharing: YES. Countries: 15. Publications: 1.

controlledIPD-YESFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.